PDE5A and idiopathic interstitial pneumonia: Interestingly, in case 3 (mild IPF and severe PH), many clinicians chose dual therapy with a PDE5 inhibitor and an ERA, despite evidence that the use of ERAs could worsen hypoxia without an increase in efficacy (18, 19).